Retraction Note: p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells

Retraction Note: p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells

This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12885-018-4559-3.

Bibliographic Details
Main Authors:	Xue Hou, Run Gong, Jianhua Zhan, Ting Zhou, Yuxiang Ma, Yuanyuan Zhao, Yaxiong Zhang, Gang Chen, Zhonghan Zhang, Shuxiang Ma, Xi Chen, Fangfang Gao, Shaodong Hong, Fan Luo, Wenfeng Fang, Yunpeng Yang, Yan Huang, Likun Chen, Haoxian Yang, Li Zhang
Format:	Article
Language:	English
Published:	BMC 2023-04-01
Series:	BMC Cancer
Online Access:	https://doi.org/10.1186/s12885-023-10880-9

Similar Items

p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells
by: Xue Hou, et al.
Published: (2018-06-01)

Effects of thoracic radiotherapy timing and duration on progression‐free survival in limited‐stage small cell lung cancer
by: Shen Zhao, et al.
Published: (2018-09-01)

Efficacy and Tolerability of Erlotinib 100 mg/d vs. Gefitinib 250 mg/d in EGFR-Mutated Advanced Non-small Cell Lung Cancer (E100VG250): An Open-Label, Randomized, Phase 2 Study
by: Shen Zhao, et al.
Published: (2020-11-01)

Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer
by: Zhonghan Zhang, et al.
Published: (2020-06-01)

The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)
by: Zhonghan Zhang, et al.
Published: (2019-11-01)

EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients
by: Qiufan Zheng, et al.
Published: (2020-02-01)

Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer
by: Shen Zhao, et al.
Published: (2021-10-01)

Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study
by: Jiaqing Liu, et al.
Published: (2019-04-01)

The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer
by: Yaxiong Zhang, et al.
Published: (2019-04-01)

Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing
by: Yaxiong Zhang, et al.
Published: (2019-01-01)

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis
by: Zhonghan Zhang, et al.
Published: (2019-12-01)

The efficacy of combining antiangiogenic agents with chemotherapy for patients with advanced non-small cell lung cancer who failed first-line chemotherapy: a systematic review and meta-analysis.
by: Jin Sheng, et al.
Published: (2015-01-01)

Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes?
by: Yaxiong Zhang, et al.
Published: (2019-06-01)

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis
by: Yixin Zhou, et al.
Published: (2018-12-01)

QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer: a multi-cohort, phase II study
by: Yan Huang, et al.
Published: (2024-01-01)

A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China
by: Yunpeng Yang, et al.
Published: (2016-04-01)

Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
by: Huaqiang Zhou, et al.
Published: (2021-09-01)

Multiple Measurement Vectors ISAR Imaging Algorithm Based on a Class of Linearized Bregman Iteration
by: Chen Wenfeng, et al.
Published: (2016-08-01)

The maximum tumor growth rate predicts clinical outcomes of patients with small‐cell lung cancer undergoing first‐line chemotherapy plus immune‐checkpoint inhibitor therapy
by: Xiang Chen, et al.
Published: (2023-04-01)

The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma
by: Shaodong Hong, et al.
Published: (2019-07-01)

Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy
by: Li-na He, et al.
Published: (2021-01-01)

Phase I study of camrelizumab in patients with advanced solid tumors
by: Yuxiang Ma, et al.
Published: (2023-02-01)

Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung cancer
by: Yixing Wang, et al.
Published: (2023-05-01)

Genetic Liability to Insomnia and Lung Cancer Risk: A Mendelian Randomization Analysis
by: Jiayi Shen, et al.
Published: (2021-12-01)

Chidamide plus envafolimab as subsequent treatment in advanced non‐small cell lung cancer patients resistant to anti‐PD‐1 therapy: A multicohort, open‐label, phase II trial with biomarker analysis
by: Yaxiong Zhang, et al.
Published: (2024-04-01)

Basal cell adenocarcinoma of the buccal minor salivary gland with liver metastases
by: Si Chen, et al.
Published: (2015-07-01)

Contributions of biliary epithelial cells to hepatocyte homeostasis and regeneration in zebrafish
by: Wenfeng Zhang, et al.
Published: (2021-03-01)

Quantifying the inhibitory effect of Bcl‐xl on the action of Mff using live‐cell fluorescence imaging
by: Yunyun Ma, et al.
Published: (2019-12-01)

Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition
by: Xuanye Zhang, et al.
Published: (2019-11-01)

Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma
by: Yan Huang, et al.
Published: (2021-03-01)

A CT‐based radiomics model to predict subsequent brain metastasis in patients with ALK‐rearranged non–small cell lung cancer undergoing crizotinib treatment
by: Yongluo Jiang, et al.
Published: (2022-06-01)

Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1
by: Hongsheng Wang, et al.
Published: (2023-08-01)

Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma
by: Chen Chen, et al.
Published: (2020-03-01)

Retraction Note: Down-regulation of LINC00472 promotes osteosarcoma tumorigenesis by reducing FOXO1 expressions via miR-300
by: Jingwei Zhang, et al.
Published: (2024-02-01)

Patients with exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lung cancer: a meta-analysis.
by: Yaxiong Zhang, et al.
Published: (2014-01-01)

RETRACTED ARTICLE: N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1
by: Hongsheng Wang, et al.
Published: (2019-12-01)

The Cost-effectiveness Analysis of Gefitinib or Erlotinib in the Treatment of  Advanced EGFR Mutant Non-small Cell Lung Cancer Patients
by: Yuxiang MA, et al.
Published: (2013-04-01)

Direct Conversion of Methane to Propylene
by: Yunpeng Hou, et al.
Published: (2023-01-01)

Retraction Note: Senescence impairs direct conversion of human somatic cells to neurons
by: Chong-kui Sun, et al.
Published: (2022-10-01)

Experimental Investigation: Vibration Measurement of a Rotating Blade with Digital Image Correlation and Blade Tip-Timing
by: Zhonghan Liang, et al.
Published: (2022-12-01)